Akero Therapeutics, Brinker International And Viavi Are Among Top Mid Cap Gainers Last Week (Jan 27-Jan 3

These ten mid-cap stocks were the best performers in the last week. Are they in your portfolio?

Akero Therapeutics, Inc. (NASDAQ:AKRO) shares surged 106.57% after the company reported preliminary Week 96 results from its SYMMETRY Phase 2B study of Efruxifermin. Several analysts boosted the price forecast.
Surgery Partners, Inc. (NASDAQ:SGRY) stock increased 25.44% after the company announced it received a non-binding acquisition proposal from Bain Capital Private Equity.
Flagstar Financial, Inc. (NYSE:FLG) shares rose 24.40% fter the company reported better-than-expected financial results. Barclays analyst Jared Shaw maintained an Overweight and raised the price forecast from $13 to $14.
Nextracker Inc. (NASDAQ:NXT) shares escalated 22.98% after the company reported better-than-expected 2025 fiscal-year third-quarter financial results and raised its guidance. Several analysts revised the price forecast.
Brighthouse Financial, Inc. (NASDAQ:BHF) shares are up 21.76% following a report suggesting that the company is exploring a potential sale. Barclays analyst Alex Scott upgraded the company from Equal-Weight to Overweight and raised the price forecast from $52 to $85.
Brinker International, Inc. (NYSE:EAT) stock upped 21.72% after the company reported better-than-expected second-quarter results and several analysts changed their price forecasts.
Hims & Hers Health, Inc. (NYSE:HIMS) shares were up 20.76%.
Oshkosh Corporation (NYSE:OSK) shares surged 19.38% after the company beat fourth-quarter estimates, initiated FY25 EPS guidance above expectations, and raised its quarterly dividend by 11%. Analysts boosted the price forecast on the stock.
Kingsoft Cloud Holdings (NASDAQ:KC) stock upped 16.50%, probably due to the Lunar New Year, recent AI developments in China and government efforts to boost markets.
Viavi Solutions Inc. (NASDAQ:VIAV) stock jumped 14.78% after the company reported better-than-expected second-quarter financial results.